Literature DB >> 7894218

Ectopic ACTH secretion due to a bronchopulmonary carcinoid localized by somatostatin receptor scintigraphy.

G Iser1, M Pfohl, U Dörr, E M Weiss, F J Seif.   

Abstract

We present the case of a 65-year-old woman with an adrenocorticotropic hormone (ACTH) secreting bronchopulmonary carcinoid. This patient showed the typical long history of Cushing's syndrome, including hypokaliemia, impaired glucose tolerance, high levels of ACTH and beta-endorphin, and coproduction of other peptides. At the onset of clinical symptoms in 1979 an adrenal adenoma was suspected, and left-sided adrenalectomy was performed. The symptoms soon recurred, and the diagnosis of ACTH-dependent Cushing's syndrome was made. As no ACTH-secreting tumor was found, the right adrenal was resected, and the patient was followed up regularly. Fourteen years later chest roentgenography and computed tomography revealed a para-aortic pulmonary lesion, which was suspicious for a bronchopulmonary carcinoid. ACTH and beta-endorphin were excessively, pancreatic polypeptide slightly elevated at that time. The final diagnosis was made using somatostatin receptor scintigraphy which confirmed the hormonal activity of the suspicious lesion; no additional focus was found. This method turned out to be not only a useful additional localization technique but also a promising tool for characterization and staging of a suspected ACTH-producing carcinoid. The tumor was resected curatively, and the diagnosis was confirmed histologically.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7894218     DOI: 10.1007/bf00190747

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  16 in total

Review 1.  The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

Authors:  S W Lamberts; E P Krenning; J C Reubi
Journal:  Endocr Rev       Date:  1991-11       Impact factor: 19.871

Review 2.  The diagnosis and differential diagnosis of Cushing's syndrome.

Authors:  P J Trainer; A Grossman
Journal:  Clin Endocrinol (Oxf)       Date:  1991-04       Impact factor: 3.478

Review 3.  Management of the ectopic ACTH syndrome due to thoracic carcinoids.

Authors:  H I Pass; J L Doppman; L Nieman; M Stovroff; J Vetto; J A Norton; W Travis; G P Chrousos; E H Oldfield; G B Cutler
Journal:  Ann Thorac Surg       Date:  1990-07       Impact factor: 4.330

4.  Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients.

Authors:  J L Doppman; L Nieman; D L Miller; H I Pass; R Chang; G B Cutler; M Schaaf; G P Chrousos; J A Norton; H A Ziessman
Journal:  Radiology       Date:  1989-07       Impact factor: 11.105

5.  Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide.

Authors:  G De Rosa; A Testa; I Liberale; T Pirronti; P Granone; A Picciocchi
Journal:  Exp Clin Endocrinol       Date:  1993

Review 6.  Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors:  E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal:  Eur J Nucl Med       Date:  1993-08

7.  The World Health Organization histological typing of lung tumours. Second edition.

Authors: 
Journal:  Am J Clin Pathol       Date:  1982-02       Impact factor: 2.493

Review 8.  The role of peptides and their receptors as tumor markers.

Authors:  J C Reubi
Journal:  Endocrinol Metab Clin North Am       Date:  1993-12       Impact factor: 4.741

9.  Somatostatin analogue (SMS 201-995) decreases plasma levels of corticotropin (ACTH) and corticotropin-releasing hormone in a patient with ectopic ACTH-producing tumors.

Authors:  S Suzuki; K Hashizume; M Kobayashi; K Ichikawa; Y Nishii; N Yokokawa; T Aizawa; T Yamada; T Kameya
Journal:  Endocrinol Jpn       Date:  1990-12

Review 10.  Clinical features, diagnosis, and localization of carcinoid tumors and their management.

Authors:  A I Vinik; M K McLeod; L M Fig; B Shapiro; R V Lloyd; K Cho
Journal:  Gastroenterol Clin North Am       Date:  1989-12       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.